aniracetam has been researched along with Nociceptive Pain in 1 studies
Nociceptive Pain: Dull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with aniracetam, a well-established AMPAR PAM, was able to completely prevent and reverse the development of acute antinociceptive tolerance to morphine." | 1.48 | AMPA receptor positive allosteric modulators attenuate morphine tolerance and dependence. ( Chen, H; Guo, X; He, Y; Hu, X; Tian, X; Wang, ZJ; Zhou, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X | 1 |
| Tian, X | 1 |
| Guo, X | 1 |
| He, Y | 1 |
| Chen, H | 1 |
| Zhou, J | 1 |
| Wang, ZJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| (2R,6R)-Hydroxynorketamine a Novel Therapeutic Analgesic for the Treatment of Neuropathic Pain: A Randomized Double Blind Cross-Over Trial.[NCT05864053] | Phase 1/Phase 2 | 25 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for aniracetam and Nociceptive Pain
| Article | Year |
|---|---|
AMPA receptor positive allosteric modulators attenuate morphine tolerance and dependence.
Topics: Allosteric Regulation; Analgesics; Animals; Dose-Response Relationship, Drug; Excitatory Amino Acid | 2018 |